Sale!

CLN8 Gene Ceroid lipofuscinosis neuronal type 8 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CLN8 gene ceroid lipofuscinosis neuronal type 8 genetic test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CLN8 gene, which are linked to a form of neuronal ceroid lipofuscinosis (NCL). NCLs are a group of progressive genetic disorders known as lysosomal storage diseases, which primarily affect the nervous system. Patients with mutations in the CLN8 gene typically exhibit symptoms such as seizures, visual impairment, cognitive decline, and motor dysfunction, with the severity and onset age varying among individuals.

The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the CLN8 gene. This precise genetic testing can be crucial for early diagnosis, allowing for better management of the condition, genetic counseling, and informing family planning decisions.

DNA Labs UAE offers this specialized genetic test for a cost of 4400 AED. The price reflects the intricate technology and expertise required to accurately identify mutations in the CLN8 gene and provide individuals and families with critical information about this rare genetic disorder. Early detection through this test can play a significant role in managing the symptoms and improving the quality of life for those affected by neuronal ceroid lipofuscinosis type 8.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CLN8 Gene Ceroid lipofuscinosis neuronal type 8 Genetic Test

Components: CLN8 Gene Ceroid lipofuscinosis neuronal type 8 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CLN8 Gene Ceroid lipofuscinosis neuronal type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 8.

Test Details

The CLN8 gene is associated with a rare neurodegenerative disorder called Ceroid Lipofuscinosis Neuronal Type 8 (CLN8). This disorder is characterized by the accumulation of lipopigments in various tissues, including the brain and other organs. CLN8 gene mutations can lead to a loss of function of the CLN8 protein, which is involved in the transport and processing of lipids within cells.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. It can be used to identify mutations or variations in the CLN8 gene and other genes associated with neurodegenerative disorders. NGS testing is often used when a specific genetic disorder is suspected but the underlying genetic cause is unknown or when multiple genes need to be analyzed simultaneously.

The CLN8 NGS genetic test involves obtaining a DNA sample, usually through a blood or saliva sample, and sequencing the CLN8 gene and potentially other relevant genes. The resulting sequence data is then analyzed to identify any mutations or variations in the CLN8 gene that may be associated with the neurodegenerative disorder. This genetic test can help confirm a diagnosis of CLN8-related neuronal ceroid lipofuscinosis and provide information about the specific genetic mutation present. It can also be used for carrier testing and prenatal testing in families with a known CLN8 gene mutation.

It is important to note that genetic testing for CLN8 and other neurodegenerative disorders should be performed and interpreted by qualified healthcare professionals with expertise in genetics and genetic counseling. The results of genetic testing can have significant implications for individuals and their families, and genetic counseling is often recommended to discuss the implications and potential next steps.

Test Name CLN8 Gene Ceroid lipofuscinosis neuronal type 8 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CLN8 Gene Ceroid lipofuscinosis neuronal type 8 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 8
Test Details

The CLN8 gene is associated with a rare neurodegenerative disorder called Ceroid Lipofuscinosis Neuronal Type 8 (CLN8). This disorder is characterized by the accumulation of lipopigments in various tissues, including the brain and other organs. CLN8 gene mutations can lead to a loss of function of the CLN8 protein, which is involved in the transport and processing of lipids within cells.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. It can be used to identify mutations or variations in the CLN8 gene and other genes associated with neurodegenerative disorders. NGS testing is often used when a specific genetic disorder is suspected but the underlying genetic cause is unknown or when multiple genes need to be analyzed simultaneously.

The CLN8 NGS genetic test involves obtaining a DNA sample, usually through a blood or saliva sample, and sequencing the CLN8 gene and potentially other relevant genes. The resulting sequence data is then analyzed to identify any mutations or variations in the CLN8 gene that may be associated with the neurodegenerative disorder.

This genetic test can help confirm a diagnosis of CLN8-related neuronal ceroid lipofuscinosis and provide information about the specific genetic mutation present. It can also be used for carrier testing and prenatal testing in families with a known CLN8 gene mutation.

It is important to note that genetic testing for CLN8 and other neurodegenerative disorders should be performed and interpreted by qualified healthcare professionals with expertise in genetics and genetic counseling. The results of genetic testing can have significant implications for individuals and their families, and genetic counseling is often recommended to discuss the implications and potential next steps.